{
  "ticker": "LLY",
  "target_date": "2025-05-27",
  "actual_date": "2025-05-27",
  "collected_at": "2025-12-08T11:48:55.468664",
  "price": {
    "open": 714.41,
    "high": 728.64,
    "low": 711.72,
    "close": 722.5693969726562,
    "volume": 3792700,
    "change_1d_pct": 1.61,
    "change_7d_pct": -0.9,
    "change_30d_pct": -0.78
  },
  "technicals": {
    "rsi_14": 38.1,
    "sma_20": 763.67,
    "sma_50": 786.1,
    "macd": -23.343,
    "macd_signal": -19.941,
    "macd_histogram": -3.402,
    "bb_upper": 868.77,
    "bb_lower": 658.57,
    "price_vs_sma20_pct": -5.38,
    "price_vs_sma50_pct": -8.08,
    "volume_ratio": 0.74
  },
  "fundamentals": {
    "market_cap": 892046213120,
    "pe_ratio": 48.75453,
    "forward_pe": 43.913506,
    "price_to_book": 37.465363,
    "price_to_sales": 15.012609,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.52
  },
  "macro": {
    "spy": {
      "price": 587.78,
      "change_1d_pct": 2.08,
      "change_7d_pct": -0.51
    },
    "vix": {
      "level": 18.96,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.43
    },
    "dollar_index": {
      "level": 99.52
    },
    "gold": {
      "price": 3299.1
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Jim Cramer Notes Eli Lilly (LLY) Stock is at a \u201cDecent Level to Start a Position\u201d",
      "source": "Yahoo",
      "datetime": 1748382870,
      "summary": "We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer\u2019s thoughts on Eli Lilly and Company (NYSE:LLY) were, a",
      "url": "https://finnhub.io/api/news?id=88e5d0865b581f1762271f77f6666d9416d39dfb2a8d56e24b2453f97f995d2c"
    },
    {
      "headline": "Sector Update: Health Care Stocks Advance Late Afternoon",
      "source": "Yahoo",
      "datetime": 1748376073,
      "summary": "Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index rising 1.5% and the",
      "url": "https://finnhub.io/api/news?id=b2ecce1ffadd74ff529e4232e0e71816080a3dd47e0288256cb3e7d53c6e88d0"
    },
    {
      "headline": "Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition",
      "source": "Yahoo",
      "datetime": 1748373907,
      "summary": "Eli Lilly and Company (NYSE:LLY) is expanding its footprint into the non-opioid pain management market in pursuit of growth opportunities. On May 27, the company announced the inking of an agreement to acquire SiteOne therapeutics. The company is acquiring the private biotech company in a deal worth",
      "url": "https://finnhub.io/api/news?id=5168a1fbfe75ea0fb6c502af1175081877e06710574525f9627a6a446f641423"
    },
    {
      "headline": "Eli Lilly Strikes up to $1 Billion Deal for SiteOne Therapeutics in Bid to Grow Pain Drug Pipeline",
      "source": "Yahoo",
      "datetime": 1748373121,
      "summary": "Eli Lilly (LLY) has agreed to acquire privately held SiteOne Therapeutics in a deal worth up to $1 b",
      "url": "https://finnhub.io/api/news?id=e3e028cf2c81d5dae278dd4057b4ec25fa14df526ac5d10908a23ffcb1ffcb80"
    },
    {
      "headline": "Eli Lilly to expand pain pipeline with $1bn SiteOne buyout",
      "source": "Yahoo",
      "datetime": 1748366758,
      "summary": "The deal prepares for a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids.",
      "url": "https://finnhub.io/api/news?id=ae5a2fccb2f40bf1351d0b131e6ce7ddc8021726efcb8617fe0d53171311a719"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}